uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Reduced Expression of CD62L Is Associated with Increased ADAM1 7 Activity and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
Show others and affiliations
2014 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 124, no 21Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 124, no 21
National Category
URN: urn:nbn:se:uu:diva-247857ISI: 000349243506012OAI: oai:DiVA.org:uu-247857DiVA: diva2:798821
56th Annual Meeting of the American-Society-of-Hematology, DEC 06-09, 2014, San Francisco, CA
Available from: 2015-03-27 Created: 2015-03-24 Last updated: 2015-03-27Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Loskog, Angelica
By organisation
Clinical Immunology
In the same journal

Search outside of DiVA

GoogleGoogle Scholar

Total: 268 hits
ReferencesLink to record
Permanent link

Direct link